Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio's Approved Drugs Database

Abelcet

Amphotericin B

Download PDF containing detailed information. PDF Version

Image Results

Press Releases About Abelcet:
Another LNA-based RNA Inhibitor Enters Clinical Trials	20th March, 2009	Santaris Pharma A/S	COPENHAGEN, March 20 /PRNewswire/ -- Santaris Pharma announced today that the fourth LNA-based drug has been brought into the clinic. In the USA several patients with cancer have now been treated
Fungal infections: From specialty area to expanded population	1st January, 1970	Datamonitor	Fungal infections: From specialty area to expanded population According to new research from Datamonitor, out of nine million patients at-risk, 1.2 million

Companies working in the area of Abelcet from Bioportfolio's Biocorporate database :
Company Name
Enzon Pharmaceuticals We are a biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and other life-threatening diseases. Our specialized sales force... www.enzon.com/ View full profile

This page has been viewed 85 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Abelcet across BioPortfolio, or for Abelcet Research Reports

Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

BioPortfolio's Approved Drugs Database

Abelcet

Amphotericin B

Image Results

Press Releases About Abelcet:

Companies working in the area of Abelcet from Bioportfolio's Biocorporate database :

Enzon Pharmaceuticals